Ibandronic acid monosodium salt, monohydrate corresponding to ibandronic acid 6mg (6ml) concentrate vial: injection.

Ind; C/I; S/E: See above under the text.

Dosage & admin: In general patients with osteolytic bone metastases require lower doses than patients with the humoral type of hyper- calcaemia. In patients with mild to moderate hypercalcaemia (albumin-corrected serum calcium <3mmol/l or <12mg/dl) 2mg is an effective dose. In most patients with severe hypercalcaemia (albumin-corrected serum calcium =3mmol/l or =12mg/dl) 4mg will be an adequate dosage. The highest dose used in clinical trials was 6mg but this dose does not add any further benefit in terms of efficacy. Adults & elderly: Prior to treatment with iba­ndronic acid the patient should be adequately rehydrated with 0.9% sodium chloride. Consideration should be given to the severity of the hypercalcaemia as well as the tumour type.

Note: For further information, please consult manufacturer's literature.

Price: 6mg vial x l's pack: 20,200.00 TP